FDA Warning Letter — Sichuan Deebio Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Sichuan Deebio Pharmaceutical Co., Ltd. on February 5, 2024 (Deyang, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Sichuan Deebio Pharmaceutical Co., Ltd.
- Date
- February 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Center
- CDER
- Location
- Deyang (China)